Long's team is dedicated to the research of mitochondrial nutrients and drugs, creating mitochondrial nutrients and drugs for mitochondrial-related chronic diseases (Alzheimer's disease, diabetes, etc.) and mitochondrial metabolism remodeling in extreme environments, and developing targeted regulatory strategies for preventing and treating mitochondrial-related diseases.

 The team has 7 professors, associate professors and assistant professors, and more than 20 master's and doctoral students, with a complete talent echelon, outstanding teaching and research capabilities, and active teamwork.

 The team maintains extensive cooperation with Harvard University, Oxford University, Kyushu University and other internationally renowned research teams, and invites researchers from China Astronaut Center, Academy of Military Science, Shaanxi Pharmaceutical Group, Honghui Hospital and other important cooperative units to serve as collaborative mentors.

 In recent years, the team has presided over over more than 10 provincial and ministerial projects such as the National Basic Research Program of China and the Natural Science Foundation of China, and has published more than 10 research papers in the J Neurosci, Cell research, Antioxidant redox research and the National Academy of Sciences of China. He has published more than 140 papers in J Neurosci, Cell research, Antioxidant redox signaling and other international and domestic journals.

The team has published more than 160 research papers in international journals including Cell Research, Cell Death & Disease, Advanced Science, Free Radical Biology and Medicine and Journal of Pharmaceutical Analysis. The group currently consists of 7 faculty members (professors, associate professors and assistant professors), more than 30 PhD and MS students, and several postdoctoral fellows, forming a well-structured research team in mitochondrial biomedicine. Internal collaborators include Prof. Yu Kong, Prof. Shuiyun Yang, Prof. Yali Zhang, Prof. Deyu Meng and Prof. Yunhua Peng.